Coldstream Laboratories Names Head of Formulation Development - - BioPharm International

ADVERTISEMENT

Coldstream Laboratories Names Head of Formulation Development



Untitled Document

Coldstream Laboratories, a provider of sterile drug product development and manufacturing services, has named Adrian Raiche, PhD, as director of formulation development. In this position, Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization, and scale-up activities for manufacturing in the company’s sterile manufacturing facility.

Raiche has experience in several aspects of pharmaceutical development, including lyophilization and potent compound handling.  Most recently, he served as manager of pharmaceutical development at Summit Biosciences contributing to formulation, analytical, and process development of nasal-spray products.  Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals, and Bausch and Lomb. 

Source: Coldstream Laboratories

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
September 26, 2014
Author Guidelines

Click here